BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11818159)

  • 1. The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.
    Singh G; Parker S; Hobart P
    Vaccine; 2002 Jan; 20(9-10):1400-11. PubMed ID: 11818159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination.
    Meleshko AN; Vashkevich KP; Fomina EG; Scheslenok EP; Schkolina TV; Sergeev GV
    Exp Oncol; 2013 Mar; 35(1):8-14. PubMed ID: 23528309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma.
    Patel KG; Ng PP; Levy S; Levy R; Swartz JR
    Protein Expr Purif; 2011 Jan; 75(1):15-20. PubMed ID: 20851769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
    Ashour AK; Petersen JL; McIlhaney MM; Vose JM; Solheim JC
    Hybridoma (Larchmt); 2006 Oct; 25(5):306-8. PubMed ID: 17044787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity.
    Penichet ML; Dela Cruz JS; Challita-Eid PM; Rosenblatt JD; Morrison SL
    Cancer Immunol Immunother; 2001 Feb; 49(12):649-62. PubMed ID: 11258791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.
    Neeson P; Pan ZK; Paterson Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):493-505. PubMed ID: 17876582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.
    Syrengelas AD; Levy R
    J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
    Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of expression plasmid for fused idiotypic DNA vaccine of B-cell lymphoma].
    Wang FX; Zhang Y; Zhao B; Pan L; Zhang XJ; Luo JM; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1453-8. PubMed ID: 20030925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine.
    Cha SC; Qin H; Sakamaki I; Kwak L
    Methods Mol Biol; 2014; 1139():289-303. PubMed ID: 24619688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and expression of a prokaryotic expression plasmid of idiotypic vaccine against B cell lymphoma: encoding the fusion genes of single-chain variable fragment and MCP-3].
    Wang FX; Zhao B; Cheng YH; Pan L; Luo JM; Zhang XJ; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1151-5. PubMed ID: 17204183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
    Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
    Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW; Young HA; Pennington RW; Weeks SD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.